Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis
{{output}}
Dimethyl fumarate (DMF) is an oral, disease-modifying agent for the treatment of relapsing-remitting multiple sclerosis (RRMS). However, details regarding its mode of action are still emerging. It is believed that the mode of action of DMF involves both nuclea... ...
